| Related Articles |
Optimizing Statins and Ezetimibe in Guideline-Focused Management.
Cardiol Clin. 2018 May;36(2):221-223
Authors: Bin Abdulhak AA, Robinson JG
Abstract
Statins are essential medications in the management of patients with clinical atherosclerotic cardiovascular disease, and have been supported by numerous clinical trials. Emerging evidence suggests that adding ezetimibe to statin therapy is associated with a net benefit and improved hard clinical outcomes, particularly in patients with significantly elevated atherosclerotic cardiovascular disease risk and elevated low-density lipoprotein cholesterol levels.
PMID: 29609751 [PubMed - in process]